Doris Moser
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Doris Moser has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
- Adelheid Elbe-Bürger
Medical University of Vienna
4 shared publications - Karl Kuchler
Medical University of Vienna, Center for Medical Biochemistry, Max Perutz Labs Vienna, Campus Vienna Biocenter, Dr. Bohr-Gasse 9/2, 1030 Vienna, Austria
4 shared publications - Trinh Phan-Canh
Max Perutz Labs, Vienna Biocenter Campus (VBC)
4 shared publications - Saskia Seiser
Medical University of Vienna, Department of Dermatology, Währinger Gürtel 18-20, 1090 Vienna, Austria
3 shared publications Andrej Knarr
Max Perutz Labs Vienna, Vienna, Austria
2 shared publications- Christian Freystätter
Department of Plastic, Reconstructive and Aesthetic Surgery, Vienna General Hospital, Medical University of Vienna, 1090 Vienna, Austria
2 shared publications
Latest Publications
- Open Access
- 26 June 2026
- Published by Elsevier in Journal of Investigative Dermatology
Human keratinocytes and fibroblasts coordinate early cutaneous innate defenses against Candida auris
- 26 June 2026
- Published by Elsevier in Journal of Investigative Dermatology
Open AccessHuman keratinocytes and fibroblasts coordinate early cutaneous innate defenses against Candida auris
- Open Access
- 23 December 2025
- Published by Springer Nature in Nature Microbiology
- Vol. 11 (2) , 461-475
Candida auris skin tropism and antifungal resistance are mediated by carbonic anhydrase Nce103
The pronounced skin tropism and pan-antifungal resistance of Candida auris pose a serious global health threat. A key question in C. auris biology is how clinical isolates acquire amphotericin B resistance. Here we demonstrate that a carbonic sensing pathway (CSP) contributes to amphotericin B resistance by modulating mitochondrial energy functions in clinical C. auris isolates. Integrated transcriptomics and proteomics identify the carbonic anhydrase Nce103 and its transcription factors Rca1 and Efg1 as important regulatory components of the CSP. The conversion of CO 2 into bicarbonate sustains energy metabolism required for colonization and fitness on human skin and in nutrient-limited microenvironments. We also show that bacterial skin colonizers engage urease to release CO 2 that sustains C. auris fitness and skin colonization. These findings highlight therapeutic options to re-sensitize C. auris to antifungal treatments, as well as to prevent skin colonization by blocking the CSP.
- 23 December 2025
- Published by Springer Nature in Nature Microbiology
- Vol. 11 (2) , 461-475
Open AccessCandida auris skin tropism and antifungal resistance are mediated by carbonic anhydrase Nce103
The pronounced skin tropism and pan-antifungal resistance of Candida auris pose a serious global health threat. A key question in C. auris biology is how clinical isolates acquire amphotericin B resistance. Here we demonstrate that a carbonic sensing pathway (CSP) contributes to amphotericin B resistance by modulating mitochondrial energy functions in clinical C. auris isolates. Integrated transcriptomics and proteomics identify the carbonic anhydrase Nce103 and its transcription factors Rca1 and Efg1 as important regulatory components of the CSP. The conversion of CO 2 into bicarbonate sustains energy metabolism required for colonization and fitness on human skin and in nutrient-limited microenvironments. We also show that bacterial skin colonizers engage urease to release CO 2 that sustains C. auris fitness and skin colonization. These findings highlight therapeutic options to re-sensitize C. auris to antifungal treatments, as well as to prevent skin colonization by blocking the CSP.
- Open Access
- 25 July 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 27034
Octenidine effectively reduces Candida auris colonisation on human skin
Candidozyma (formerly Candida) auris (C. auris), a WHO critical priority pathogen known for its multi-drug resistance and strong skin tropism, is posing a significant health threat. This study evaluates the efficacy of commercial octenidine-based antiseptics in reducing C. auris colonisation on intact and wounded human skin. Using an established ex vivo human skin model to simulate clinical settings, skin samples from healthy donors were exposed to planktonic C. auris cells. Six hours post-contamination, two ready-to-use octenidine-based antiseptics were applied, and fungal colonisation was assessed after 18 h via periodic acid-Schiff staining, bright field and scanning electron microscopy and colony forming unit quantification. In vitro biofilm assays with various C. auris strains, including drug resistant ones, were performed to determine the antifungal effects of octenidine formulations. Results showed that octenidine-based antiseptics significantly reduced C. auris viability on intact and wounded human skin, and also demonstrated a nearly complete eradication across tested strains in vitro. These findings highlight the potential of octenidine-based products in reducing C. auris colonisation, supporting infection prevention and control strategies in healthcare settings and enhancing patient safety.
- 25 July 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 27034
Open AccessOctenidine effectively reduces Candida auris colonisation on human skin
Candidozyma (formerly Candida) auris (C. auris), a WHO critical priority pathogen known for its multi-drug resistance and strong skin tropism, is posing a significant health threat. This study evaluates the efficacy of commercial octenidine-based antiseptics in reducing C. auris colonisation on intact and wounded human skin. Using an established ex vivo human skin model to simulate clinical settings, skin samples from healthy donors were exposed to planktonic C. auris cells. Six hours post-contamination, two ready-to-use octenidine-based antiseptics were applied, and fungal colonisation was assessed after 18 h via periodic acid-Schiff staining, bright field and scanning electron microscopy and colony forming unit quantification. In vitro biofilm assays with various C. auris strains, including drug resistant ones, were performed to determine the antifungal effects of octenidine formulations. Results showed that octenidine-based antiseptics significantly reduced C. auris viability on intact and wounded human skin, and also demonstrated a nearly complete eradication across tested strains in vitro. These findings highlight the potential of octenidine-based products in reducing C. auris colonisation, supporting infection prevention and control strategies in healthcare settings and enhancing patient safety.
- Open Access
Carbon Dioxide Controls Fungal Fitness and Skin Tropism of Candida auris
The pronounced skin tropism and pan-antifungal resistance traits of the fungal pathogen Candida auris stand out as a serious health threat. Here, we show that a carbonic sensing pathway (CSP) promotes development of resistance to amphotericin B through a reactive oxygen species (ROS) response, as well as ectopic cell wall and membrane lipid homeostasis. Mechanistically, the transcription factor Rca1 acts in cooperation with Efg1 to control the expression and activity of the carbonic anhydrase Nce103 as a key effector component. The conversion of carbon dioxide to bicarbonate provides a direct link to energy metabolism, facilitating colonization and growth on skin tissues. Native mouse and human skin models unequivocally show that the CSP is essential for maintaining skin tropism as well as fungal fitness. Curiously, upon ablation of Rca1 and Efg1, C. auris debilitates efficient growth on native skin. Collectively, our findings highlight critical roles of the CSP in C. auris skin tropism and antifungal drug resistance. The work suggests therapeutic options for disrupting skin colonization and thus preventing infections. Highlights: ✓ Proteo-transcriptomics links a carbonic sensing pathway (CSP) to C. auris multidrug resistance ✓ The Nce103 carbonic anhydrase controls drug resistance as a key component of the CSP ✓ The transcription factors Rca1 and Efg1 control Nce103 and link CSP with C. auris skin tropism ✓ CSP acts through ectopic ROS response, cell wall architecture and membrane lipid function ✓ CSP is required for C. auris fitness and efficient growth and colonization of skin tissues Result contents: ✓ Integrated omics reveals multidrug-resistant mechanisms in C. auris ✓ CO 2 -sensing controls amphotericin B resistance (AMB R ) traits through Rca1 and Efg1 ✓ The carbonic anhydrase Nce103 governs susceptibility to amphotericin B ✓ The CSP influences AMB R by maintaining reactive oxygen species homeostasis ✓ The CSP controls AMB R via cell membrane and cell wall remodelling ✓ The CSP regulates fungal fitness through controlling energy metabolism ✓ C. auris requires the CSP for skin colonization
Open AccessCarbon Dioxide Controls Fungal Fitness and Skin Tropism of Candida auris
The pronounced skin tropism and pan-antifungal resistance traits of the fungal pathogen Candida auris stand out as a serious health threat. Here, we show that a carbonic sensing pathway (CSP) promotes development of resistance to amphotericin B through a reactive oxygen species (ROS) response, as well as ectopic cell wall and membrane lipid homeostasis. Mechanistically, the transcription factor Rca1 acts in cooperation with Efg1 to control the expression and activity of the carbonic anhydrase Nce103 as a key effector component. The conversion of carbon dioxide to bicarbonate provides a direct link to energy metabolism, facilitating colonization and growth on skin tissues. Native mouse and human skin models unequivocally show that the CSP is essential for maintaining skin tropism as well as fungal fitness. Curiously, upon ablation of Rca1 and Efg1, C. auris debilitates efficient growth on native skin. Collectively, our findings highlight critical roles of the CSP in C. auris skin tropism and antifungal drug resistance. The work suggests therapeutic options for disrupting skin colonization and thus preventing infections. Highlights: ✓ Proteo-transcriptomics links a carbonic sensing pathway (CSP) to C. auris multidrug resistance ✓ The Nce103 carbonic anhydrase controls drug resistance as a key component of the CSP ✓ The transcription factors Rca1 and Efg1 control Nce103 and link CSP with C. auris skin tropism ✓ CSP acts through ectopic ROS response, cell wall architecture and membrane lipid function ✓ CSP is required for C. auris fitness and efficient growth and colonization of skin tissues Result contents: ✓ Integrated omics reveals multidrug-resistant mechanisms in C. auris ✓ CO 2 -sensing controls amphotericin B resistance (AMB R ) traits through Rca1 and Efg1 ✓ The carbonic anhydrase Nce103 governs susceptibility to amphotericin B ✓ The CSP influences AMB R by maintaining reactive oxygen species homeostasis ✓ The CSP controls AMB R via cell membrane and cell wall remodelling ✓ The CSP regulates fungal fitness through controlling energy metabolism ✓ C. auris requires the CSP for skin colonization
- Open Access
- 1 December 2021
- Published by Elsevier in Journal of Medical Mycology
- Vol. 31 (4) , 101178
The effectiveness of surface disinfectants and a micellic H2O2 based water disinfectant on Candida auris
- 1 December 2021
- Published by Elsevier in Journal of Medical Mycology
- Vol. 31 (4) , 101178
Open AccessThe effectiveness of surface disinfectants and a micellic H2O2 based water disinfectant on Candida auris
- 1 July 2010
- Published by Georg Thieme Verlag KG in Homeopathy
- Vol. 99 (3) , 177-182
Heparin-binding epidermal growth factor expression in KATO-III cells after Helicobacter pylori stimulation under the influence of strychnos Nux vomica and Calendula officinalis
Introduction: Previous studies have shown the stimulating effect of Helicobacter pylori on the gene expression of heparin-binding epidermal growth factor (HB-EGF) using the gastric epithelial cell line KATO-III. Strychnos Nux vomica (Nux vomica) and Calendula officinalis are used in highly diluted form in homeopathic medicine to treat patients suffering from gastritis and gastric ulcers. Aim and method: To investigate the influence of Nux vomica and Calendula officinalis on HB-EGF-like growth factor gene expression in KATO-III cells under the stimulation of H. pylori strain N6 using real-time PCR with and without addition of Nux vomica and Calendula officinalis as a 10c or 12c potency. Results: Baseline expression and stimulation were similar to previous experiments, addition of Nux vomica 10c and Calendula officinalis 10c in a 43% ethanolic solution led to a significant reduction of H. pylori induced increase in gene expression of HB-EGF (reduced to 53.12 ± 0.95% and 75.32 ± 1.16% vs. control; p < 0.05), respectively. Nux vomica 12c reduced HB-EGF gene expression even in dilutions beyond Avogadro’s number (55.77 ± 1.09%; p < 0.05). Nux vomica 12c in a 21.5% ethanol showed a smaller effect (71.80 ± 3.91%, p < 0.05). This effect was only be observed when the drugs were primarily prepared in ethanol, not in aqueous solutions. The data suggest that both drugs prepared in ethanolic solution are potent inhibitors of H. pylori induced gene expression.
- 1 July 2010
- Published by Georg Thieme Verlag KG in Homeopathy
- Vol. 99 (3) , 177-182
Heparin-binding epidermal growth factor expression in KATO-III cells after Helicobacter pylori stimulation under the influence of strychnos Nux vomica and Calendula officinalis
Introduction: Previous studies have shown the stimulating effect of Helicobacter pylori on the gene expression of heparin-binding epidermal growth factor (HB-EGF) using the gastric epithelial cell line KATO-III. Strychnos Nux vomica (Nux vomica) and Calendula officinalis are used in highly diluted form in homeopathic medicine to treat patients suffering from gastritis and gastric ulcers. Aim and method: To investigate the influence of Nux vomica and Calendula officinalis on HB-EGF-like growth factor gene expression in KATO-III cells under the stimulation of H. pylori strain N6 using real-time PCR with and without addition of Nux vomica and Calendula officinalis as a 10c or 12c potency. Results: Baseline expression and stimulation were similar to previous experiments, addition of Nux vomica 10c and Calendula officinalis 10c in a 43% ethanolic solution led to a significant reduction of H. pylori induced increase in gene expression of HB-EGF (reduced to 53.12 ± 0.95% and 75.32 ± 1.16% vs. control; p < 0.05), respectively. Nux vomica 12c reduced HB-EGF gene expression even in dilutions beyond Avogadro’s number (55.77 ± 1.09%; p < 0.05). Nux vomica 12c in a 21.5% ethanol showed a smaller effect (71.80 ± 3.91%, p < 0.05). This effect was only be observed when the drugs were primarily prepared in ethanol, not in aqueous solutions. The data suggest that both drugs prepared in ethanolic solution are potent inhibitors of H. pylori induced gene expression.